Myriad Genetics reported $-17800000 in EBITDA for its fiscal quarter ending in March of 2025.


Ebitda Change Date
Agilent USD 466M 14M Jul/2025
Becton, Dickinson and Co. USD 1.47B 81M Jun/2025
Bio-Rad Laboratories USD 467.2M 372.2M Jun/2025
Bruker USD 128.1M 27.1M Jun/2025
Danaher USD 1.34B 543M Jun/2025
Exact Sciences USD 138.22M 173.88M Jun/2025
Hologic USD 334M 26.7M Jun/2025
Illumina USD 399M 168M Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Mettler Toledo International USD 295.89M 43.87M Jun/2025
Myriad Genetics USD -17800000 15.7M Mar/2025
Quest Diagnostics USD 570M 65M Jun/2025
Quidel USD 106.8M 33.8M Jun/2025
Repligen USD 32.18M 9.36M Jun/2025
Revvity USD 209.29M 22.24M Jun/2025
Standard Biotools USD -14279000 11.5M Jun/2025
Thermo Fisher Scientific USD 3.06B 541M Jun/2025
Veracyte USD 35.78M 29.25M Jun/2025
Waters USD 276.28M 74.81M Jun/2025